Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Thomson Reuters ONE 11/26/2014 2:00 AM ETOffer Memorandum and Position Statement on SHV's offer expected early December Nutreco N.V. ("Nutreco") announces that it has been informed by SHV Holdings N.V. ("SHV") that the publication of the Offer Memorandum by SHV with regard to its intended cash offer for all Nutreco ordinary shares is expected to be published early December. Nutreco is expected to issue its Position Statement at the same date. Nutreco further reports that the offer process is on track. In accordance with market practice and regulatory requirements, the Offer Memorandum to be issued by SHV and the Position Statement to be issued by Nutreco will amongst others include detailed information on the process and the Boards' decision-making leading to the offer, their financial assessment of the offer and its strategic rationale. Furthermore, it contains the fairness opinions issued to the Nutreco Boards by its financial advisors, transaction structure, governance and minority protection as well as the arrangements, including non-financial arrangements, between Nutreco and SHV. This information will address questions from shareholders and other stakeholders that Nutreco has received to date. On 10 November 2014, Nutreco and SHV jointly announced that SHV had agreed to increase its offer price per ordinary share from € 40 (cum dividend) in cash to € 44.50 (cum dividend) in cash for all issued and outstanding ordinary shares in the capital of Nutreco (the "Increased Offer"). By agreeing the Increased Offer price with respect to the intended public offer, SHV responded to an expression of interest which Nutreco had received from Cargill, Incorporated ("Cargill") on 8 November 2014. Nutreco has understood from Cargill that they are evaluating the situation. Nutreco has not received further information since its public announcement on 10 November 2014. The boards of Nutreco will continue to act in accordance with their fiduciary duties taking into account the interests of its shareholders and all other stakeholders. This publication follows earlier public announcements of Nutreco and SHV on 20 October 2014 and 10 November 2014. Nutreco will issue additional statements if and when appropriate. This is an announcement in accordance with Section 4, paragraph 1 of the Netherlands Decree on Public Takeover Bids (Besluit openbare biedingen Wft) and Section 5:25i paragraph 2 of the Dutch Financial Supervision Act (Wet op het financieel toezicht). END OF PRESS RELEASE
"Nutreco has understood from Cargill that they are evaluating the situation. Nutreco has not received further information since its public announcement on 10 November 2014." Interessante opmerking...SHV/Nutreco verkeren in onzekerheid...t.a.v. plannen van Cargill.
55.000 aandelen in de laat bij 45,95 euro
Vitavita schreef op 26 november 2014 10:40 :
55.000 aandelen in de
laat bij 45,95 euro
...en foetsie
en loopt bij Nutreco nu weer langzaam de lucht uit de koers, net als voor enkele weken geleden? Richting 44,50/45,00 dan maar?
Vitavita schreef op 26 november 2014 11:05 :
[...]
...en foetsie
en foetsie = niet verkocht en niet gekocht en niet in de omzet
"Nutreco shores up defence ahead of potential Cargill counter-offer" Merrill Lynch en Skadden Arp zijn als extra adviseurs aangetrokken. Zie artikel in Financial Times.
Moet niet gekker worden. Laat Cargill maar toe slaan!
zozo dit is zeker goed nieuws!
heerlijk ik had al zo'n vermoeden!
heeft iemand dit bericht?
Nutreco, the Dutch fish and animal feed group that has agreed to a €3bn takeover by SHV Holdings, has bolstered its advisory line up ahead of a potential new bid by US commodities trading group Cargill. The Dutch company has appointed Bank of America Merrill Lynch and US law group Skadden Arps, alongside advisers at ING Corporate Finance and De Brauw Blackstone Westbroek. More ON THIS TOPIC Lex Nutreco - fishy food Shareholders urge Nutreco to open books Comment Cargill set to lock horns in fight over Nutreco SHV raises bid for feed group Nutreco IN EUROPEAN COMPANIES European boards become more international Eurosceptics harm recovery, warn chiefs Russian groups’ financing struggles Ikea franchise arm rearranged financing Sign up now firstFT FirstFT is our new essential daily email briefing of the best stories from across the web Nutreco said that the advisers were brought on to give its board “extra insight in and understanding of the US perspective”. The move comes as some shareholders have expressed frustration with the lack of a competitive auction process before Nutreco agreed to €40 a share offer from SHV in October that valued the company at €2.7bn. The initial deal agreement prompted Cargill and Permira to approach the company with an informal offer of €43.20 a share in early November. Nutreco swiftly rejected the approach and said it was recommending a new cash offer from SHV for €44.50 a share. Under the agreement between Nutreco and SHV, any competing offer must be at least 8 per cent higher than the current recommended bid, or €48.06 a share. Shares in Nutreco on Friday closed at €45.98, indicating that shareholders expect a counter offer. It is unclear whether Cargill and Permira will make a fresh approach. In the past Cargill has only pursued agreed deals rather than going hostile on a target. Both companies declined to comment. Details of SHV’s bid will be set out in its offer document, which is expected to be published as soon as this week alongside Nutreco’s position statement. One reason for Nutreco’s rejection of Cargill and Permira’s approach was the plans to break the group into two. Cargill, which already owns a fish feed business, would take Nutreco’s fish operations, while Permira would buy the animal feed unit. Under the deal with SHV, senior Nutreco executives would remain with the company and would receive completion bonuses.
aha..dus alles laten slagen en dan een bonus opstrijken..eigen belang dus?
wat vind je van dit nieuws tampie?
Eerlijk? Ik heb me nauwelijks in het geheel verdiept. Ik heb 8 calls dec 45,00 gekocht omdat ik hoopte op een overnamestrijd. En het lijkt er op dat de strijd is begonnen. Maar vraag me niet om een analyse. Ik hoop alleen dat de koers de komende weken richting 50 euro gaat. Sorry dat ik verder weinig inhoudelijks kan bijdragen aan dit forum
EU mergers and takeovers (Dec 2) FIRST-STAGE REVIEWS BY DEADLINE JAN 8 -- Dutch investment firm SHV to acquire Dutch animal feed and nutrition company Nutreco (notified Nov. 24/deadline Jan. 8/simplified)
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
Nextensa
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Indices
AEX
918,72
-0,64%
EUR/USD
1,0706
-0,31%
FTSE 100
8.146,86
-0,21%
Germany40^
18.004,30
-1,43%
Gold spot
2.332,68
0,00%
NY-Nasdaq Composite
17.688,88
+0,12%
Stijgers
Dalers